**AI驱动的病理学云平台Proscia完成900万美元C+轮融资**
全球领先的数字病理软件供应商Proscia今日宣布，成功在C+轮融资中筹集900万美元，使得该轮融资的总金额达到了4600万美元。本轮融资由知名投资机构Highline Capital Management和Triangle Peak Partners领投，其中包括Alpha Intelligence Capital、Scale Venture Partners以及Hitachi Ventures等现有投资者的积极参与。
筹集的这笔资金将被Proscia用于加速其商业扩张，同时深度研发针对生命科学和诊断实验室的人工智能应用程序。Proscia的AI驱动平台已经在病理学领域展现出巨大的潜力，通过优化工作流程、提升诊断准确性和效率，为医疗健康行业带来了革命性的变化。
此次融资的顺利完成，标志着Proscia在推动病理学数字化和智能化的道路上迈出了坚实的一步。随着资金的注入，该公司有望进一步巩固其市场领先地位，同时加速创新，以满足全球范围内对精准医疗和高效诊断日益增长的需求。
Proscia的首席执行官表示，他们对于能得到如此强大的投资者群体的支持感到非常荣幸，并将致力于利用这笔资金推动病理学的边界，以改善全球患者的医疗体验和健康结果。
英语如下：
**AI-Powered Pathology Platform Proscia Secures $9 Million in C+ Round Funding**
Proscia, a global leader in digital pathology software, has announced the completion of a $9 million C+ funding round, bringing the total raised in this round to $46 million. The round was led by Highline Capital Management and Triangle Peak Partners, with strong participation from existing investors Alpha Intelligence Capital, Scale Venture Partners, and Hitachi Ventures.
The funds raised will enable Proscia to accelerate its commercial expansion and deepen its development of artificial intelligence (AI) applications for life sciences and diagnostic laboratories. Proscia’s AI-driven platform has already demonstrated significant potential in pathology, transforming workflows, enhancing diagnostic accuracy, and boosting efficiency within the healthcare sector.
This successful funding round underscores Proscia’s commitment to advancing digital and intelligent pathology. With the injection of capital, the company is poised to solidify its market leadership and accelerate innovation to meet the growing global demand for precision medicine and efficient diagnoses.
The CEO of Proscia expressed gratitude for the support from such a strong investor base and vowed to leverage the funds to push the boundaries of pathology, thereby improving healthcare experiences and health outcomes for patients worldwide.
【来源】https://venturebeat.com/ai/proscias-46m-series-c-propels-ai-driven-pathology-into-the-mainstream/
Views: 1